Primary Site >> Colorectal Cancer

Gene >> RAD9A

Journal: Anticancer Drugs. 2006 Nov;17(10):1171-7.
Title: The DNA damage checkpoint is activated during residual tumour cell survival to methotrexate treatment as an initial step of acquired drug resistance.
Author: de Anta, Josep M|Perez-Castro, Antonio J|Freire, Raimundo|Mayol, Xavier
PMID: 17075316
Journal: Nucleic Acids Res. 2013 Apr;41(7):4093-103.
Title: Understanding the role of the Q338H MUTYH variant in oxidative damage repair.
Author: Turco, Eleonora|Ventura, Ilenia|Minoprio, Anna|Russo, Maria Teresa|Torreri, Paola|Degan, Paolo|Molatore, Sara|Ranzani, Guglielmina Nadia|Bignami, Margherita|Mazzei, Filomena
PMID: 23460202
Journal: DNA Repair (Amst). 2015 Oct;34:39-51.
Title: Distinct functional consequences of MUTYH variants associated with colorectal cancer: Damaged DNA affinity, glycosylase activity and interaction with PCNA and Hus1.
Author: Brinkmeyer, Megan K|David, Sheila S
PMID: 26377631
Journal: Zhonghua Zhong Liu Za Zhi. 2016 May 23;38(5):351-6.
Title: [Effects of Rad9 mutants with impaired DNA mismatch repair function on tumorigenesis of colorectal cancer].
Author: Kong, M|An, L L|Hu, Z S|Li, K M|Zhao, Y|Cai, Z Y|Sun, J Y|Wang, H F|Zhang, S C|Zhang, Z Y
PMID: 27188607
Journal: Carcinogenesis. 2018 May 28;39(6):788-797.
Title: Mlh1 deficiency in normal mouse colon mucosa associates with chromosomally unstable colon cancer.
Author: Pussila, Marjaana|Toronen, Petri|Einarsdottir, Elisabet|Katayama, Shintaro|Krjutskov, Kaarel|Holm, Liisa|Kere, Juha|Peltomaki, Paivi|Makinen, Markus J|Linden, Jere|Nystrom, Minna
PMID: 29701748